You are here Home Resources and guidance Sponsors Reach Pharmaceuticals Pty Ltd Regulatory activities for this sponsor. Listen Print Share LinkedIn (Twitter) Facebook Email Loading... Type ARTG (15) Prescription medicine registration (8) Designation or determination (6) Australian public assessment report (AusPar) (2) Prescription medicine decision summary (1) Prescription medicine evaluation (1) Date 2025 (9) 2024 (5) 2023 (6) 2022 (9) 2021 (1) 2020 (2) 2018 (1) Search Sponsor content33 result(s) found, displaying 31 to 33 Notice for thiotepa (Reach Pharmaceuticals Pty Ltd) 7 January 2021 Designation or determination Orphan drug Notice for trientine hydrochloride (Reach Pharmaceuticals Pty Ltd) 30 October 2020 Designation or determination Orphan drug Metabolics L-Carnitine (301883) 16 April 2018 ARTG Australian Register of Therapeutic Goods (ARTG) information for Metabolics L-Carnitine. Pages First page « First Previous page ‹ Previous Page 1 Page 2 Page 3 Current page 4
Notice for thiotepa (Reach Pharmaceuticals Pty Ltd) 7 January 2021 Designation or determination Orphan drug
Notice for trientine hydrochloride (Reach Pharmaceuticals Pty Ltd) 30 October 2020 Designation or determination Orphan drug
Metabolics L-Carnitine (301883) 16 April 2018 ARTG Australian Register of Therapeutic Goods (ARTG) information for Metabolics L-Carnitine.